DelveInsight, the leading market research and consulting company has added new report LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists – Pipeline Insights, 2015 to its portfolio. DelveInsight has made…
Month: August 2015
Aug 10
![New Approach Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors]( "New Approach Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors")
New Approach Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors
Introduction: Cardiovascular disease is the leading cause of mortality worldwide due to increased level of Low Density Lipoprotein, cholesterol, which is a major modifiable risk factor….
